Health Archive » April, 2007

Health - April, 2007

128 articles

• Katrina Patients Class Action Stays In State Court
• Controlling Health Care Costs With Wellness Programs
• FDA Rejects Merck's Latest COX-2 Drug
• Judge Orders Synergetics To Reply To Rival's Claim
• Title VII Suit Against Kidney Service To Proceed
• Blue Cross Settles Doctor Fraud Claims For $128M
• EU Court Tentatively OK's Branded Drug Resale
• Experts Praise Patent Reform, Suggest Changes
• Tax Traps for Health System Parent Entities
• Lawyers Win More For Plaintiffs In Glaxo Settlement
• Dental Co. Sued For Alleged Monopolistic Practices
• Brazil Threatens To Break Merck's Efavirenz Patent
• U.S. Joins Medicare Fraud Whistleblower Case
• Royal Philips Settles Defibrillator Dispute
• Hospital Sued For Alleged X-Ray Conspiracy
• Abbott Unit Defeats Inequitable Conduct Claims
• Claim Constructions Adopted In Medtronic v. Cordis
• Becton Dickinson Licensing Deals Under Scrutiny
• EU Parliament OK's Rules For Gene Therapy Industry
• Greenberg, Attorney Dispute Malpractice Suit
• Court Dismisses Suit Over Talking Defibrillator
• Teva v. Novartis: Post-MedImmune Declaratory Judgment
• Cardinal Health Tags $600M For Securities Settlement
• Pepper Hamilton Welcomes Two Health Specialists
• Complaint Granted In Novartis Bone Drug Case
• Kentucky River Case Causes Workforce Scrutiny
• Supreme Court Ditches Medicaid Kickback Case
• Novartis Dismisses Some Exelon Patent Claims
• Judge's Ruling Will Suspend Texas Vioxx Suits
• Scrushy Keeps Home In $81M SEC Settlement
• Federal Circuit Affirms Ruling On Prilosec Process
• Amgen Exec's Spouse Settles Fraud Charge
• Wyeth Sues To Protect Its Best-Selling Drug
• Mayer Brown Advises AstraZeneca On Acquisition
• Declaratory Judgment Sought Over Allergy Patent
• Loeb & Loeb Picks Up Patent Litigator
• Scrushy Makes Bid For New Trial
• Judge Refuses To Toss Intuitive Suit Against Caltech
• Probation Not Enough For Ex-HealthSouth Official
• $100M Workers Comp Scam Yields 5 Indictments
• Three Rivers Sues Rival Over Hep C Treatment
• Greenberg Traurig Hit With Malpractice Suit
• FDA Blocks New Generic Versions Of Pfizer's Norvasc
• Court Nixes Retaliation Claim Against St. Luke's
• MedPointe Sues Apotex Over Allergy Treatments
• Teva Fights For Biaxin Marketing Rights
• FDA Revitalization Bill Progresses In Senate
• Cutera Beamed By Securities Suit
• Hospitals, Doctors Join Action Against Blue Cross
• Authorized Generics Benefit Consumers: Report
• DOJ Official Says Reverse Payments Not Illegal
• Senate Blocks Medicare Drug Bill
• PDL Biopharma Sues to Protect Cardene I.V.
• Roche's Bid For Stay Denied In HIV Technology Case
• FDA Seizes Products From Device Maker
• ICU To Pay Attorneys' Fees To Alaris In Patent Case
• Shareholders Sue Amgen Over Anemia Drugs
• J&J Unit, NYU Sue Abbott Over Humira
• Cell Therapeutics Pays Up In Off-Label Marketing Case
• High Court Hears Home Care Worker's Wage Case
• Novozymes Wins $15M From Danish Rival
• Maryland Backs Down In "Wal-Mart Law" Fight
• Texas AG Sues CVS For Dumping Customer Records
• Warner Chilcott Settles Second Ovcon Case
• After Divestiture, FTC To Allow Drug Acquistion
• Ariad Sues Amgen, Wyeth Over Enbrel
• Biotech Cos. Settle Trade Secrets Spat
• Suit Alleges Hospital Monopoly Over Imaging Services
• Court Upholds Ex-HealthSouth VP's Conviction
• Injunction Against Stryker Vacated
• Medicare Drug Bill Passes Senate Committee
• Governors Send Support For Biologic Bill
• Judge Tosses Vioxx Securities Suit
• Court Rules Against J&J Unit In Artificial Disc Case
• Panel Confirms Shoddy Conditions At Walter Reed
• Appeals Court Upholds Injunction On Generic Topamax
• Emerging Weapons Against Generics Competition
• Teva Targets 13th Drug Maker In Zoloft Patent Battle
• Fed. Circ. Upholds Ruling Against Generic Acular
• Health Insurer Sued Under RICO
• Antitrust Allegations Add Fire To Catheter Dispute
• Authorized Generics In Spotlight At Senate Hearing
• Judge Dismisses Fosamax Case
• Despite Definite Veto, Senate Pushes Stem Cell Bill
• Abbott Backs Down In Kaletra Pricing Fight
• Juries Side With Doctors: Study
• Merck Sues To Block Generic Singulair
• Eye Surgery Rivals Settle Patent Claims For $6.5M
• Miracle Drug Or Overdose?
• Judge Orders More Monitoring Of Scrushy
• Bayer Sues Teva Over Patents For Avelox
• Jury Awards Doctor $6.3M
• AstraZeneca Hits Sandoz With Seroquel Patent Suit
• India Begs Novartis To Drop Patent Challenge
• Ex-Endocare Execs On The Hook For Fraud Charges
• J&J Wins Patent Fight Over Drug Stent
• J&J Fires Back At Sales Rep In Overtime Pay Suit
• USPTO To Reissue Seasonale Patent
• Outstanding Women: Patricia Meador
• Insulation Cos. Plead Guilty To Bid-Rigging
• Negotiating Medicare Fees Would Save $30B: Study
• Invalid Patent Correction Leads To Reversal
• Judge Certifies New Claim In Abbott Class Action
• Johnson & Johnson Pays $11M To End Antitrust Suit
• VaxGen Receives $11M Consolation Prize
• Shareholders Target Lilly Over Zyprexa
• California Sued Over Law For HIV Patients
• St. Vincent Wants Caritas To Pay Up
• Judge Tosses Case For Failure To Prove Scienter
• Pfizer's U.K. Drug Distribution Deal Draws Scutiny
• Hospitals Get Go-Ahead To Sue Transcribers For Fraud
• Outstanding Women: Linda Friedman
• PTO Rejects Claims On Stem Cell Patents
• Drug Companies Spend Record On Lobbying
• Senate Eyes Penn. Health Insurers' Merger
• Palomar, Alma End Light-Based Hair Removal Suit
• Bristol-Myers Subpoenaed Over Plavix Deal
• Outstanding Women: Elisabeth Belmont
• Circuit Court Rules On "Fiduciary Exception"
• Pfizer Pays $34.7M To Settle Genotropin Charges
• Options Backdating Catches Up To Biomet
• Tenet To Pay $10M To Settle With SEC
• N.Y. Health Provider Labels Becton Anti-Competitive
• Purdue, Impax Settle Oxycontin Litigation
• Medtronic Wins Appeal In Spinal Screw Patent Suit
• Outstanding Women: Elizabeth Carder-Thompson
• Physician Sentenced For Securities, Medicare Fraud
• High Court Refuses Ranbaxy's Lipitor Appeal